1ATK | A:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR E-64 |
1AU0 | A:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC DIACYLAMINOMETHYL KETONE INHIBITOR |
1AU2 | A:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE INHIBITOR |
1AU3 | A:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR |
1AU4 | A:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR |
1AYU | A:1-215 | CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC BISCARBOHYDRAZIDE INHIBITOR |
1AYV | A:1-215 | CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT THIAZOLHYDRAZIDE INHIBITOR |
1AYW | A:1-215 | CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT BENZYLOXYBENZOYLCARBOHYDRAZIDE INHIBITOR |
1BGO | A:1-215 | CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC INHIBITOR |
1BY8 | A:5-314 | THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K |
1CB5 | A:54-454; B:54-454; C:54-454 | HUMAN BLEOMYCIN HYDROLASE. |
1CJL | A:5P-220 | CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORM |
1CS8 | A:1P-220 | CRYSTAL STRUCTURE OF PROCATHEPSIN L |
1CSB | B:50-254; E:50-254 | CRYSTAL STRUCTURE OF CATHEPSIN B INHIBITED WITH CA030 AT 2.1 ANGSTROMS RESOLUTION: A BASIS FOR THE DESIGN OF SPECIFIC EPOXYSUCCINYL INHIBITORS |
1DEU | B:4P-242; A:6P-242 | CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN X: A CYSTEINE PROTEASE WITH THE PROREGION COVALENTLY LINKED TO THE ACTIVE SITE CYSTEINE |
1EF7 | A:1-242; B:1-242 | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN X |
1FH0 | A:1-220; B:2001-2220 | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN V COMPLEXED WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR |
1GLO | A:1-217 | CRYSTAL STRUCTURE OF CYS25SER MUTANT OF HUMAN CATHEPSIN S |
1GMY | B:0-252; C:0-252; A:0-253 | CATHEPSIN B COMPLEXED WITH DIPEPTIDYL NITRILE INHIBITOR |
1HUC | B:50-254; D:50-254 | THE REFINED 2.15 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF HUMAN LIVER CATHEPSIN B: THE STRUCTURAL BASIS FOR ITS SPECIFICITY |
1ICF | A:1-175; C:1-175 | CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L |
1K3B | B:215-358 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C): EXCLUSION DOMAIN ADDED TO AN ENDOPEPTIDASE FRAMEWORK CREATES THE MACHINE FOR ACTIVATION OF GRANULAR SERINE PROTEASES |
1M6D | A:1-212; B:1-212 | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN F |
1MEM | A:1-211 | CRYSTAL STRUCTURE OF CATHEPSIN K COMPLEXED WITH A POTENT VINYL SULFONE INHIBITOR |
1MHW | A:1-174; B:1-174 | DESIGN OF NON-COVALENT INHIBITORS OF HUMAN CATHEPSIN L. FROM THE 96-RESIDUE PROREGION TO OPTIMIZED TRIPEPTIDES |
1MS6 | A:1-217 | DIPEPTIDE NITRILE INHIBITOR BOUND TO CATHEPSIN S. |
1NL6 | A:1-215; B:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR |
1NLJ | A:1-215; B:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR |
1NPZ | A:1-217; B:251-467 | CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES |
1NQC | A:1-217 | CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES |
1PBH | A:1A-254 | CRYSTAL STRUCTURE OF HUMAN RECOMBINANT PROCATHEPSIN B AT 3.2 ANGSTROM RESOLUTION |
1Q6K | A:1-215 | CATHEPSIN K COMPLEXED WITH T-BUTYL(1S)-1-CYCLOHEXYL-2-OXOETHYLCARBAMATE |
1SNK | A:2-215 | CATHEPSIN K COMPLEXED WITH CARBAMATE DERIVATIZED NORLEUCINE ALDEHYDE |
1TU6 | A:115-329; B:115-329 | CATHEPSIN K COMPLEXED WITH A KETOAMIDE INHIBITOR |
1U9V | A:1-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABE854 |
1U9W | A:0-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABI491 |
1U9X | A:0-215 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABJ688 |
1VSN | A:1-211 | CRYSTAL STRUCTURE OF A POTENT SMALL MOLECULE INHIBITOR BOUND TO CATHEPSIN K |
1YK7 | A:1-215 | CATHEPSIN K COMPLEXED WITH A CYANOPYRROLIDINE INHIBITOR |
1YK8 | A:117-329 | CATHEPSIN K COMPLEXED WITH A CYANAMIDE-BASED INHIBITOR |
1YT7 | A:2-215 | CATHEPSIN K COMPLEXED WITH A CONSTRAINED KETOAMIDE INHIBITOR |
2ATO | A:1-215 | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN K IN COMPLEX WITH MYOCRISIN |
2AUX | A:3-215 | CATHEPSIN K COMPLEXED WITH A SEMICARBAZONE INHIBITOR |
2AUZ | A:1-215 | CATHEPSIN K COMPLEXED WITH A SEMICARBAZONE INHIBITOR |
2BDL | A:1-215 | CATHEPSIN K COMPLEXED WITH A PYRROLIDINE KETOAMIDE-BASED INHIBITOR |
2C0Y | A:3-316 | THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN S |
2CB5 | A:54-454; B:54-454 | HUMAN BLEOMYCIN HYDROLASE, C73S/DELE455 MUTANT |
2DJF | B:215-358 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C) IN COMPLEX WITH THE INHIBITOR GLY-PHE-CHN2 |
2DJG | B:215-358 | RE-DETERMINATION OF THE NATIVE STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C) |
2F1G | A:-2-217; B:1-217 | CATHEPSIN S IN COMPLEX WITH NON-COVALENT 2-(BENZOXAZOL-2-YLAMINO)-ACETAMIDE |
2FQ9 | A:0-218; B:1-218 | CATHEPSIN S WITH NITRILE INHIBITOR |
2FRA | B:0-218; A:1-218 | HUMAN CATHEPSIN S WITH CRA-27934, A NITRILE INHIBITOR |
2FRQ | A:0-218; B:1-218 | HUMAN CATHEPSIN S WITH INHIBITOR CRA-26871 |
2FT2 | B:0-218; A:1-218 | HUMAN CATHEPSIN S WITH INHIBITOR CRA-29728 |
2FUD | A:0-218; B:1-218 | HUMAN CATHEPSIN S WITH INHIBITOR CRA-27566 |
2FYE | A:1-211 | MUTANT HUMAN CATHEPSIN S WITH IRREVERSIBLE INHIBITOR CRA-14013 |
2G6D | A:1-211 | HUMAN CATHEPSIN S MUTANT WITH VINYL SULFONE INHIBITOR CRA-14009 |
2G7Y | B:0-218; A:1-218 | HUMAN CATHEPSIN S WITH INHIBITOR CRA-16981 |
2H7J | A:0-217; B:1-217 | CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A NONPEPTIDIC INHIBITOR. |
2HH5 | A:1-217; B:1-217 | CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A ZINC MEDIATED NON-COVALENT ARYLAMINOETHYL AMIDE |
2HHN | A:-2-217; B:1-217 | CATHEPSIN S IN COMPLEX WITH NON COVALENT ARYLAMINOETHYL AMIDE. |
2HXZ | B:0-217; A:1-217; C:1-217 | CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A NONPEPTIDIC INHIBITOR (HEXAGONAL SPACEGROUP) |
2IPP | B:50-254 | CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HUMAN LIVER CATHEPSIN B |
2OP3 | A:1-217; B:1-217 | THE STRUCTURE OF CATHEPSIN S WITH A NOVEL 2-ARYLPHENOXYACETALDEHYDE INHIBITOR DERIVED BY THE SUBSTRATE ACTIVITY SCREENING (SAS) METHOD |
2PBH | A:1A-254 | CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 3.3 ANGSTROM RESOLUTION |
2R6N | A:0-215 | CRYSTAL STRUCTURE OF A PYRROLOPYRIMIDINE INHIBITOR IN COMPLEX WITH HUMAN CATHEPSIN K |
2R9M | A:1-217; B:1-217 | CATHEPSIN S COMPLEXED WITH COMPOUND 15 |
2R9N | A:1-217; B:1-217 | CATHEPSIN S COMPLEXED WITH COMPOUND 26 |
2R9O | A:1-217; B:1-217 | CATHEPSIN S COMPLEXED WITH COMPOUND 8 |
2VHS | A:1-220; B:1-220; C:1-220; D:1-220 | CATHSILICATEIN, A CHIMERA |
3BC3 | A:1-220; B:1-220 | EXPLORING INHIBITOR BINDING AT THE S SUBSITES OF CATHEPSIN L |
3C9E | A:1-215 | CRYSTAL STRUCTURE OF THE CATHEPSIN K : CHONDROITIN SULFATE COMPLEX. |
3CBJ | A:60P-255 | CHAGASIN-CATHEPSIN B COMPLEX |
3CBK | A:61P-255 | CHAGASIN-CATHEPSIN B |
3H6S | A:1-221; B:1-221; C:1-221; D:1-221 | STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX |
3H7D | A:1-215; E:1-215 | THE CRYSTAL STRUCTURE OF THE CATHEPSIN K VARIANT M5 IN COMPLEX WITH CHONDROITIN-4-SULFATE |
3H89 | A:1-220; B:1-220; C:1-220; D:1-220; E:1-220; F:1-220 | A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF CATHEPSIN-L RETRO-BINDING INHIBITORS(COMPOUND 4) |
3H8B | A:1-220; B:1-220; C:1-220; D:1-220; E:1-220; F:1-220 | A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF CATHEPSIN-L RETRO-BINDING INHIBITORS(COMPOUND 9) |
3H8C | A:1-220; B:1-220 | A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF CATHEPSIN-L RETRO-BINDING INHIBITORS (COMPOUND 14) |
3HHA | A:1-220; D:1-220; B:1-220; C:1-220 | CRYSTAL STRUCTURE OF CATHEPSIN L IN COMPLEX WITH AZ12878478 |
3HWN | C:1-220; B:1-220; D:1-220; A:1-220 | CATHEPSIN L WITH AZ13010160 |
3IEJ | A:-1-219; B:0-220 | PYRAZOLE-BASED CATHEPSIN S INHIBITORS WITH ARYLALKYNES AS P1 BINDING ELEMENTS |
3IV2 | A:2-220; B:1-220 | CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT |
3K24 | A:1-220; B:1-220 | CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT IN COMPLEX WITH GLN-LEU-ALA PEPTIDE |
3K9M | A:1-254; B:1-254 | CATHEPSIN B IN COMPLEX WITH STEFIN A |
3KW9 | A:1-215 | X-RAY STRUCTURE OF CATHEPSIN K COVALENTLY BOUND TO A TRIAZINE LIGAND |
3KWB | X:1001-1215; Y:2006-2215 | STRUCTURE OF CATK COVALENTLY BOUND TO A DIOXO-TRIAZINE INHIBITOR |
3KWN | A:1-219; B:1-219 | CATHEPSIN S IN COMPLEX WITH THIOETHER ACETAMIDE P3 INHIBITOR |
3KWZ | A:1-215 | CATHEPSIN K IN COMPLEX WITH A NON-SELECTIVE 2-CYANO-PYRIMIDINE INHIBITOR |
3KX1 | A:3-215 | CATHEPSIN K IN COMPLEX WITH A SELECTIVE 2-CYANO-PYRIMIDINE INHIBITOR |
3PBH | A:1A-254 | REFINED CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 2.5 ANGSTROM RESOLUTION |
7PCK | D:1P-215; C:1P-215; B:1P-215; A:1P-215 | CRYSTAL STRUCTURE OF WILD TYPE HUMAN PROCATHEPSIN K |